GET DAILY SIGNALSZepp Health (ZEPP) Guides for a Revenue Decline of 4% to 10% in Q3 2026
Key Takeaways
- Zepp Health guided third quarter of 2026 net revenue to a range of $68.0 million to $73.0 million, implying a year-over-year decline of roughly 4% to 10%.
- The comparison is unusually difficult: revenue in the third quarter of 2025 jumped 78.5% year over year to $75.8 million, creating a high base.
- Management expects supply constraints on the Bip series and Helio Strap to ease, with Helio Strap seen reaching full supply in the fourth quarter.
- Gross margin faces headwinds from higher memory and component costs plus a stronger Chinese yuan, partially offset by a shift toward premium products.
- In the prior quarter, revenue rose 6.9% year over year to $63.5 million, but the net loss widened to $11.3 million.
- Investors will watch gross margin, the operating-loss trajectory, and any update to the company's full-year growth outlook.
- For more context on this ticker, explore its Major News, Today's Price Move, Price Targets, and Forecast pages for additional data and analysis.
- Discover automated trading ideas by exploring Trending AI Robots for signal-driven market insights.
Why This Quarter Stands Out for Zepp Health
Zepp Health Corporation (ZEPP), the global smart-wearables company behind the Amazfit, Zepp Clarity, and Zepp Aura brands, is set to report results for the third quarter of 2026. The report comes at a pivotal moment. After several quarters of double-digit top-line growth, management has guided for a year-over-year revenue decline, reflecting both a tough comparison base and lingering supply constraints on key products such as the Bip series and Helio Strap. At the same time, the company is managing rising memory and component costs driven by the broader semiconductor shift toward DDR5 and high-bandwidth memory. Because the stock is a small-cap with limited sell-side coverage, the report serves as the primary gauge of whether premiumization and supply recovery can offset margin pressures and stabilize profitability. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
Revenue Guidance and Profitability Focus
Zepp Health does not benefit from broad Wall Street coverage, so management's own guidance is the central benchmark for this quarterly earnings release. The company has said it expects third-quarter 2026 net revenue of $68.0 million to $73.0 million, which would represent a year-over-year decline of approximately 4% to 10% from the $75.8 million reported in the third quarter of 2025. Management has attributed the expected decline primarily to a high comparison base rather than weakening demand, noting that product mix and consumer demand continued to improve during July and August.
On profitability, investors are watching gross margin closely. In the second quarter of 2026, gross margin was 37.4%, up from 36.2% a year earlier but down from 37.7% in the first quarter, as higher memory costs and a stronger Chinese yuan partially offset the benefits of a richer product mix. The company's net loss also widened to $11.3 million, or $0.72 per American Depositary Share (ADS), in the second quarter, reflecting elevated spending tied to a launch-heavy first half. Key metrics to monitor this quarter include the pace of supply recovery for the Bip series and Helio Strap, selling and marketing expense normalization, and any commentary on the trajectory toward a return to growth in the fourth quarter.
Market Sentiment Heading Into the Report
Sentiment heading into the report is cautious. Zepp Health shares have traded well below their 52-week high, and the company's guided revenue decline, combined with widening losses in recent quarters, has kept the stock under pressure. The market's focus is likely to be on whether reported revenue lands within the guided range and whether gross margin holds up against rising component costs. Historically, small-cap wearables names with thin liquidity can see outsized moves around earnings, and any surprise on supply recovery or margin resilience could shape near-term sentiment. Key risks include slower-than-expected easing of Helio Strap supply, further memory-cost inflation, and foreign-exchange headwinds from a stronger yuan. From what I see, this makes the upcoming numbers especially important to track.
Forward Signals Worth Monitoring
Beyond the headline revenue figure, investors will want to track several forward-looking signals in the third quarter of 2026 earnings report and accompanying commentary.
Supply recovery is the first watch item. Management has said restrictions on the Bip series have been largely removed and that Helio Strap should reach full supply in the fourth quarter. Confirmation of this timeline would support the company's stated goal of returning to top-line growth in the fourth quarter and keeping the full year on a growth trajectory.
Margin and cost trends are a second area of focus. The industry-wide transition to DDR5 and high-bandwidth memory, driven by AI and data-center demand, is raising component prices. Zepp Health has responded by securing diversified supply channels and has announced price increases across the entire Bip family beginning in January 2027. The effectiveness of those actions will shape profitability over the coming quarters.
Finally, expense discipline matters. Selling and marketing costs surged in the first half of 2026 because of a heavy product-launch calendar, but management expects those costs to moderate as launch activity slows. A clear path toward a narrower operating loss, combined with the company's $106.3 million cash position, would give investors more confidence in the balance sheet and the company's long-term brand strategy. I’m watching this closely as the quarter unfolds.
Exploring AI Tools in My Research Process
In my analysis of names like ZEPP, I often turn to Tickeron’s AI Screener to quickly filter peers and spot technical setups that might otherwise take hours to identify manually. The tool lets me apply customizable screens around fundamentals, volatility, and AI signals, which helps surface comparable ideas in the wearables space without replacing my own judgment on the numbers.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Contributor
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
ZEPP in -5.98% downward trend, falling for three consecutive days on October 30, 2026
Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where ZEPP declined for three days, in 276 of 308 cases, the price declined further within the following month. The odds of a continued downward trend are 90%.
Technical Analysis (Indicators)
Bearish Trend Analysis
The Aroon Indicator for ZEPP entered a downward trend on November 02, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Bullish Trend Analysis
The RSI Indicator shows that the ticker has stayed in the oversold zone for 16 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 16 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a +2.23% 3-day Advance, the price is estimated to grow further. Considering data from situations where ZEPP advanced for three days, in 174 of 220 cases, the price rose further within the following month. The odds of a continued upward trend are 79%.
ZEPP may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 8 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 14 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.177) is normal, around the industry mean (3.841). P/E Ratio (-0.820) is within average values for comparable stocks, (4.044). Projected Growth (PEG Ratio) (1.780) is also within normal values, averaging (4.647). Dividend Yield (0.179) settles around the average of (1.690) among similar stocks. P/S Ratio (0.245) is also within normal values, averaging (4.260).
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is 95 (best 1 - 100 worst), indicating slightly worse than average price growth. ZEPP’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 96 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ZEPP’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
a provider of pre-K-12 education solutions, delivering content, technology, services and media
Industry ComputerPeripherals
Advertisement